awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38221980-1189DED8-9CC7-4F7D-87CB-FC2B6D94E766
Q38221980-1189DED8-9CC7-4F7D-87CB-FC2B6D94E766
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221980-1189DED8-9CC7-4F7D-87CB-FC2B6D94E766
Clinical implication of SGLT2 inhibitors in type 2 diabetes.
P2860
Q38221980-1189DED8-9CC7-4F7D-87CB-FC2B6D94E766
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221980-1189DED8-9CC7-4F7D-87CB-FC2B6D94E766
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be35d303b785af473773e0b264188ec197a43756
P2860
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.